Kamal Al-Rabi (Kamal Alrabi)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Systematic Review

Advanced Non Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Ejection Fraction

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Akram N Al-Ibraheem, Ahmed Saad Abdlkadir, Egesta Lopci, Sudqi Allouzi, Diana Paez, Maryam Alkuwari, Mohammad Ma'koseh, Fuad Novruzov, Sharjeel Usmani, Kamal Al-Rabi, Asem H Mansour
FDG-PET in Chimeric Antigen Receptor T-Cell (CAR T-Cell) Therapy Toxicity: A Systematic Review. Cancers 16 (9) (2024)
Akram N Al-Ibraheem, Ahmed Saad Abdlkadir, Egesta Lopci, Sudqi Allouzi, Diana Paez, Maryam Alkuwari, Mohammad Ma'koseh, Fuad Novruzov, Sharjeel Usmani, Kamal Al-Rabi, Asem H Mansour
FDG-PET in Chimeric Antigen Receptor T-Cell (CAR T-Cell) Therapy Toxicity: A Systematic Review. Cancers 16 (9) (2024)
Jordi Remon, Benjamin Besse, Santiago Ponce Aix, Ana Callejo, Kamal Al-Rabi, Reyes Bernabe, Laurent Greillier, Margarita Majem, Noemí Reguart, Isabelle Monnet, Sophie Cousin, Pilar Garrido Lopez, Gilles Robinet, Rosario Garcia Campelo, Anne Madroszyk, Julien Mazieres, Hubert Curcio, Bartosz Wasag, Yassin Pretzenbacher, Fanny Grillet, Anne-Marie C Dingemans, Rafal Dziadziuszko
Overall Survival From the EORTC LCG-1613 APPLE Trial of Osimertinib Versus Gefitinib Followed by Osimertinib in Advanced EGFR -Mutant Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Jordi Remon, Benjamin Besse, Santiago Ponce Aix, Ana Callejo, Kamal Al-Rabi, Reyes Bernabe, Laurent Greillier, Margarita Majem, Noemí Reguart, Isabelle Monnet, Sophie Cousin, Pilar Garrido Lopez, Gilles Robinet, Rosario Garcia Campelo, Anne Madroszyk, Julien Mazieres, Hubert Curcio, Bartosz Wasag, Yassin Pretzenbacher, Fanny Grillet, Anne-Marie C Dingemans, Rafal Dziadziuszko
Overall Survival From the EORTC LCG-1613 APPLE Trial of Osimertinib Versus Gefitinib Followed by Osimertinib in Advanced EGFR -Mutant Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Jordi Remon, Benjamin Besse, Santiago Ponce Aix, Ana Callejo, Kamal Al-Rabi, Reyes Bernabe, Laurent Greillier, Margarita Majem, Noemí Reguart, Isabelle Monnet, Sophie Cousin, Pilar Garrido Lopez, Gilles Robinet, Rosario Garcia Campelo, Anne Madroszyk, Julien Mazieres, Hubert Curcio, Bartosz Wasag, Yassin Pretzenbacher, Fanny Grillet, Anne-Marie C Dingemans, Rafal Dziadziuszko
Overall Survival From the EORTC LCG-1613 APPLE Trial of Osimertinib Versus Gefitinib Followed by Osimertinib in Advanced EGFR -Mutant Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Jordi Remon, Benjamin Besse, Santiago Ponce Aix, Ana Callejo, Kamal Al-Rabi, Reyes Bernabe, Laurent Greillier, Margarita Majem, Noemí Reguart, Isabelle Monnet, Sophie Cousin, Pilar Garrido Lopez, Gilles Robinet, Rosario Garcia Campelo, Anne Madroszyk, Julien Mazieres, Hubert Curcio, Bartosz Wasag, Yassin Pretzenbacher, Fanny Grillet, Anne-Marie C Dingemans, Rafal Dziadziuszko
Overall Survival From the EORTC LCG-163 APPLE Trial of Osimertinib Versus Gefitinib Followed by Osimertinib in Advanced EGFR -Mutant Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Lina Souan, Hikmat Abdel-Razeq, Sura Nashwan, Sara Al Badr, Kamal Al-Rabi, Maher A Sughayer
COVID-19 Antibody Seroconversion in Cancer Patients: Impact of Therapy Cessation-A Single-Center Study. Vaccines 11 (11) (2023)